We further demonstrated DNASE1L3 could inhibit glycolysis in the liver cancer cells and promote tricarboxylic acid cycle involved in PTPN2-HK2 and CEBPβ-p53- PFK1 pathways. The gene discussed is HK2; the disease is liver cancer.